Priority 13 from the Autosomal Dominant Polycystic Kidney Disease Project
UNCERTAINTY: What are the most effective treatments for high blood pressure (hypertension) for people (children and adults) with ADPKD? (Priority 13) | |
---|---|
Overall ranking | 13 |
JLA question ID | 0103/13 |
Explanatory note | Not available for this PSP |
Evidence |
No evidence identified |
Health Research Classification System category | Renal and urogenital |
Extra information provided by this project | |
---|---|
Original uncertainty examples | Which antihypertensive agents are most effective for hypertension in people with ADPKD? ~ Development of strategies to define second-line treatment agents for the management of hypertension in people with ADPKD. ~ What is the efficacy of aldosterone antagonists for the management of hypertension in people with ADPKD? ~ What is the impact, in people with ADPKD, of blood pressure control on kidney function? |
Submitted by | Autosomal Dominant Polycystic Kidney Disease (ADPKD): Report from a Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference (.PDF) |
Project information | |
---|---|
Project unique ID | 0103 |
Project name | Autosomal Dominant Polycystic Kidney Disease |
Total number of uncertainties identified by this project. |
35 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
Date of priority setting workshop | 15 December 2020 |